Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 647 press releases before 2018
-
AstraZeneca to Participate in Tentative FDA Psychopharmacologic Drugs Advisory Committee in June
-
AstraZeneca Issues 2008 Annual Report
-
FDA Approves Symbicort for Chronic Obstructive Pulmonary Disease
-
AstraZeneca Receives FDA Complete Response Letter On Seroquel XR For Generalised Anxiety Disorder
-
AstraZeneca PLC Board Change
-
AstraZeneca To Participate In Tentative FDA Psychopharmacologic Drugs Advisory Committee
-
AstraZeneca’s Partner, MAP Pharmaceuticals, Announces Phase III Study Of Unit Dose Budesonide In Children With Asthma Did Not Meet Primary Endpoints
-
AstraZeneca’s Partner, POZEN Informed By FDA That Gastric Ulcers Are Valid Primary Endpoint In PN 400 Trials
-
AstraZeneca PLC Fourth Quarter and Full Year Results 2008
-
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Rebecca Einhorn
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
